Triage of Patients Presenting Beyond 24 Hours With Ischemic Stroke Due to Vertebrobasilar Artery Occlusion
- Conditions
- Stroke, Ischemic
- Registration Number
- NCT06510634
- Lead Sponsor
- Tianjin Huanhu Hospital
- Brief Summary
Endovascular thrombectomy (EVT) for posterior circulation occlusion is generally performed within a window of less than 24 hours from the time the patient was last known well (LKW). The efficacy and safety of EVT beyond the 24-hour window remain uncertain.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 236
- age≥18 years.;
- blockage in the vertebrobasilar artery, including the vertebral artery or basilar artery, determined using computed tomographic angiography (CTA)/ magnetic resonance angiography (MRA)/digital subtraction angiography (DSA);
- VBAO occurrence more than 24 hours from LKW;
- none to mild premorbid disability defined by modified Rankin Scale (mRS) score ≤2;
- informed consent before enrollment in the clinical trials.
- neuroimaging evidence of cerebral hemorrhage on presentation;
- lack of follow up information on outcomes at 90 days
- serious, advanced, or terminal illness.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method proportion of patients with Modified ranking scale (mRS) (0-3) at 90 days 90(±14)days A 0-6 scale running from perfect health without symptoms to death.
- Secondary Outcome Measures
Name Time Method Mortality within 90 days 90(±14)days mortality of any causes.
distribution of patients with Modified ranking scale (mRS) (0-3) at 90 days 90(±14)days A 0-6 scale running from perfect health without symptoms to death.
Incidence of symptomatic intracranial haemorrhage 90(±14)days Symptomatic intracranial hemorrhage was characterized as any type of intracranial hemorrhage observed on follow-up imaging between 22 and 36 hours and 7 days after stroke onset, accompanied by an increase of at least 4 points on the NIHSS from baseline or the lowest value within 7 days, or resulting in mortality.
Trial Locations
- Locations (1)
Tianjin Huanhu Hospital
🇨🇳Tianjin, Tianjin, China
Tianjin Huanhu Hospital🇨🇳Tianjin, Tianjin, China